About Emcure
Emcure is a company based in Pune (India) founded in 1983 by Sunil Rajanikant Mehta. Emcure has raised $50 million across 2 funding rounds from investors including Blackstone and Bain Capital Private Equity. The company has 6,730 employees as of March 31, 2024. Emcure has completed 1 acquisition, including International Pharmaceutical Generics. Emcure offers products and services including Formulations and Biologics.
- Headquarter Pune, India
- Employees 6730 as on 31 Mar, 2024
- Founders Sunil Rajanikant Mehta
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Emcure Pharmaceuticals Limited
-
Annual Revenue
$915.21 M (USD)18.61as on Mar 31, 2025
-
Net Profit
$79.71 M (USD)36.76as on Mar 31, 2025
-
EBITDA
$164.34 M (USD)19.23as on Mar 31, 2025
-
Total Equity Funding
$50 M (USD)
in 2 rounds
-
Latest Funding Round
-
Investors
Blackstone
& 1 more
-
Employee Count
6730
as on Mar 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Emcure
Emcure is a publicly listed company on the NSE with ticker symbol EMCURE in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Emcure
Emcure offers a comprehensive portfolio of products and services, including Formulations and Biologics.
Formulations are developed and manufactured by Emcure for various therapeutic uses, enabling the provision of affordable healthcare solutions.
Biologics are produced by Emcure for treating complex diseases, including biosimilars and novel therapies that support global health needs.
Funding Insights of Emcure
Emcure has successfully raised a total of $50M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(10 Jul 2006)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2013 | Amount | Unspecified - Emcure | Valuation |
investors |
|
| Jul, 2006 | Amount | Private Equity Round - Emcure | Valuation | Blackstone |
|
Investors in Emcure
Emcure has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Blackstone and Bain Capital Private Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private investment firm managing assets and expanding into equity, credit, and real estate services.
|
Founded Year | Domain | Location | |
|
Diversified investment management is provided across multiple asset classes.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Emcure
Emcure has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include International Pharmaceutical Generics.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Generic drugs are manufactured for international distribution.
|
2005 |
Financial Statements - Emcure
Emcure Comparisons
Competitors of Emcure
Frequently Asked Questions about Emcure
Emcure was founded in 1983 and raised its 1st funding round 23 years after it was founded.
Emcure is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Emcure is a funded company, having raised a total of $50M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $50M, raised on Jul 10, 2006.
As of Mar 31, 2024, the latest employee count at Emcure is 6,730.
Annual revenue of Emcure is $915.21M as on Mar 31, 2025.
Emcure was founded in 1983 in Pune, India, within the pharmaceutical sector. Pharmaceutical products are developed, manufactured, and marketed across therapeutic areas such as gynecology, cardiology, oncology, blood disorders, HIV, respiratory, CNS, and anti-infectives. Formulations, biologics, and active pharmaceutical ingredients are also produced. Operations focus on global distribution from the Indian base.
Emcure offers Formulations and Biologics.
Yes, Emcure is publicly traded on NSE under the ticker symbol EMCURE.
Emcure has made 1 acquisition, including International Pharmaceutical Generics.
Emcure has 2 investors. Key investors include Blackstone, and Bain Capital Private Equity.
The ticker symbol of Emcure is EMCURE on NSE.
The valuation of Emcure is $367.12M as of Jul 2006.